Brown Advisory Inc Aspira Women'S Health Inc. Transaction History

Brown Advisory Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 14, 2022	BUY	$0.4 - $1.09 $3,200 - $8,720	8,000 Added 6.57%	129,727 $76,000
Q2 2022 Aug 02, 2022	BUY	$0.4 - $1.09 $3,200 - $8,720	8,000 Added 6.57%	129,727 $76,000
Q1 2022 Nov 14, 2022	SELL	$0.88 - $1.81 $7,040 - $14,480	-8,000 Reduced 6.17%	121,727 $127,000
Q4 2021 Jan 27, 2022	BUY	$1.63 - $3.43 $44,091 - $92,781	27,050 Added 28.57%	121,727 $215,000
Q3 2021 Nov 12, 2021	BUY	$3.19 - $5.48 $79,156 - $135,980	24,814 Added 35.52%	94,677 $308,000
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $40,650 - $90,920	13,550 Added 24.06%	69,863 $469,000
Q3 2020 Nov 16, 2020	BUY	$2.54 - $4.56 $58,707 - $105,395	23,113 Added 69.62%	56,313 $174,000
Q2 2020 Aug 14, 2020	BUY	$0.78 - $5.25 $25,896 - $174,300	33,200 New	33,200 $127,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.